| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acbbad5433d146bb8462ddea0fdcc1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c64233d8b53a5c8c033434a1b6d088dc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-05003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y501-03002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-05003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y501-03002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-36 |
| filingDate |
2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0e77f2479db89644350a86ba1f2645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c25042ab86817173152cafa4c41f2c2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d062baa288fe11bd44397312530e07 |
| publicationDate |
2021-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021186052-A1 |
| titleOfInvention |
Attenuated mycoplasma bacteria |
| abstract |
The present invention concerns genetically modified Mycoplasma bacteria. Also intended are methods of generating attenuated Mycoplasma bacteria and their use to produce heterologous gene products. Further intended are pharmaceutical compositions comprising the attenuated Mycoplasma bacteria described herein. |
| priorityDate |
2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |